A Phase 1/2, Open-Label Study of ADXS-503 Alone and in Combination with Pembrolizumab in Subjects with Metastatic Squamous or Non-Squamous Non-Small Cell Lung Cancer
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Advaxis Inc
Start Date
January 24, 2019
End Date
November 30, 2023
Administered By
Duke Cancer Institute
Awarded By
Advaxis Inc
Start Date
January 24, 2019
End Date
November 30, 2023